Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.23% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Mar 31, 2019
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-19-006841General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-3.24% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
38.60% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
94.59% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
83.20% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-1.49% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.65% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3.06% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.13%
- Current
- 0.23%
- Delta
- -0.90%
- Previous
- 7.74%
- Current
- -3.24%
- Delta
- -10.98%
- Previous
- 2412.55%
- Current
- 38.60%
- Delta
- -2373.95%
- Previous
- 30.05%
- Current
- 94.59%
- Delta
- 64.55%
- Previous
- 81.65%
- Current
- 83.20%
- Delta
- 1.55%
- Previous
- -18.38%
- Current
- -1.49%
- Delta
- 16.90%
- Previous
- 18.21%
- Current
- 10.65%
- Delta
- -7.56%
- Previous
- 3.39%
- Current
- 3.06%
- Delta
- -0.33%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Has State · CUMBERLAND PHARMACEUTICALS INC →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_DECREASED →Transitioned To · CPIX CASH_GENERATION_DECREASED →Transitioned To · CPIX GROWTH_DECREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_INCREASED →Transitioned To · CPIX PROFITABILITY_INCREASED →Transitioned To · CPIX R_AND_D_INTENSITY_DECREASED →Transitioned To · CPIX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.